Skip to content

Immix Biopharma, Inc. IMMX Book value per share

Book value per share at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$33.20+3.0%
AbbVie logo
AbbVieABBV
-$3.75-568%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$0.61-42.2%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$1.16-35.1%
Regenxbio logo
RegenxbioRGNX
$0.40-92.5%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$3.24-37.6%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Calculated from Immix Biopharma, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s book value per share?
Immix Biopharma, Inc. (IMMX) reported book value per share of $1.52 in Q1 2026.
How has Immix Biopharma, Inc.'s book value per share changed year-over-year?
Immix Biopharma, Inc.'s book value per share increased by 371.7% year-over-year, from $0.32 to $1.52.
What is the long-term trend for Immix Biopharma, Inc.'s book value per share?
Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s book value per share has grown at a 15.2% compound annual growth rate (CAGR), from -$1.40 to $2.85.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.